• About Us
    • Our Founder’s Story
    • Who We Are
      • Our Team
      • Board of Directors
      • Advisory Board
      • Brain Cancer Advisory Board
      • Breast Cancer Advisory Board
      • Computational Advisory Board
      • Lung Cancer Advisory Board
      • Melanoma Advisory Board
      • Prostate Cancer Advisory Board
    • Press and Events
    • Newsletters
    • Publications
    • Join Our Team
  • Patients
    • ASK Cancer Commons
    • Super Patients
  • Physicians
  • Knowledge Blog
    • Lung Cancer
    • Breast Cancer
    • Melanoma
    • Brain Cancer
    • Neuroendocrine Tumors
    • Prostate Cancer
    • Curious Dr. George
  • News
Cancer Commons
Donate 
  • Cancer Commons
  • Contact Us
  • Donate 
  • About Us
    • Our Founder’s Story
    • Who We Are
      • Our Team
      • Board of Directors
      • Advisory Board
      • Brain Cancer Advisory Board
      • Breast Cancer Advisory Board
      • Computational Advisory Board
      • Lung Cancer Advisory Board
      • Melanoma Advisory Board
      • Prostate Cancer Advisory Board
    • Press and Events
    • Newsletters
    • Publications
    • Join Our Team
  • Patients
    • ASK Cancer Commons
    • Super Patients
  • Physicians
  • Knowledge Blog
    • Lung Cancer
    • Breast Cancer
    • Melanoma
    • Brain Cancer
    • Neuroendocrine Tumors
    • Prostate Cancer
    • Curious Dr. George
  • News

Do you have a challenging case?

Cancer Commons will review your case, consult with leading cancer experts, and give you evidence-based opinions.

Our service is 100% free to patients and their families, and is entirely confidential.

Ask Cancer Commons
  • Donate Your Data
  • Home
  • News

Decade-Long Survival Possible after Ipilimumab

Cancer Discovery. Oct 17, 2013.

“A pooled analysis of data from studies of ipilimumab in patients with advanced melanoma shows that the immune checkpoint inhibitor can induce lengthy responses, with some patients still alive after nearly 10 years.”

Tags: advanced melanoma, immune checkpoint inhibitor, ipilimumab, melanoma, metastasis, metastatic melanoma, rc, survival

Company
  • Advisory Board
  • Brain Cancer Advisory Board
  • Breast Cancer Advisory Board
  • Computational Advisory Board
  • Lung Cancer Advisory Board
  • Melanoma Advisory Board
  • Prostate Cancer Advisory Board
  • About Us
    • Join Our Team
  • Terms of Use
  • Privacy Policy
Contact Us

5050 El Camino Real, Suite 215
Los Altos, CA 94022

info@cancercommons.org
650-530-3636

Stay Connected
© 2018 Cancer Commons. All rights reserved.